key: cord-0979825-g3zne3j5 authors: Choudhary, Pratik; Wilmot, Emma G.; Owen, Karissa; Patel, Dipesh C.; Mills, Lesley; Rayman, Gerry; Winocour, Peter; Ayman, Goher; Patel, Rohit; Hambling, Clare; Nagi, Dinesh K. title: A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post‐COVID‐19 era date: 2020-12-12 journal: Diabet Med DOI: 10.1111/dme.14462 sha: 342e016fe7fa8a35853645a6908132e3cac30f6e doc_id: 979825 cord_uid: g3zne3j5 A third of the over 40,000 deaths in the UK attributed to the first wave of the COVID-19 pandemic occurred in people with diabetes. However, the focus on emergency response to COVID-19 in the first few months has had a major knock-on impact on the delivery of routine clinical care for diabetes. Key challenges as we enter the second wave of the pandemic include a backlog of appointments, delays in accessing care such as structured education, and initiating insulin, GLP-1 or diabetes technology. We anticipate ongoing pressures through increased commitments to general medicine, reductions in clinic capacities due to social distancing and reorganisation of clinic spaces. Many services have already adapted by moving much of their activity to the virtual space. A third of the over 40,000 deaths in the United Kingdom attributed to the first wave of the COVID-19 pandemic occurred in people with diabetes. 1 However, the focus on emergency response to COVID-19 in the first few months has had a major knock-on impact on the delivery of routine clinical care for diabetes. Key challenges as we enter the second wave of the pandemic include a backlog of appointments, delays in accessing care such as structured education, and initiating insulin, GLP-1 or diabetes technology. 2 We anticipate ongoing pressures through increased commitments to general medicine, reductions in clinic capacities due to social distancing and reorganisation of clinic spaces. Many services have already adapted by moving much of their activity to the virtual space. 3 In the coming months, it is unlikely that we can return to normal, and so we feel it will be essential to identify patients at greatest risk and prioritise their care. These recommendations from the Association of British Clinical Diabetologists (ABCD) made together with representation from Diabetes UK and the Primary Care Diabetes Network, propose a multi-factorial risk stratification to help prioritise patients with diabetes into Urgent, Priority and Routine groups, based on key, easily available markers (Table 1) . Review URGENTLY (within 3 months). • HbA1c > 10% (86 mmol/mol). • Uncontrolled hypertension (BP > 160/100). • Complete Hypoglycaemia unawareness (Gold score 7 if available) or reported Severe hypoglycaemia in the last 12 months. • Diabetes-related admission DKA, HHS or unstable cardiac or cerebrovascular disease) in the last 12 months. • People recently discharged from hospital with changes in treatment. • eGFR < 30 ml/min or rapid decline in renal function (>15 ml/min/year). • Active diabetic foot disease. Other factors include severe mental health illness, learning difficulties, frailty or those planning pregnancy. These patients should be offered virtual or face-to-face appointments within 3 months and may need between 3 and 6 contacts in the next 12 months. Review as a PRIORITY (within 6 months). • HbA1c 8.5-10% (70-86 mmol/mol). • Suboptimal blood pressure (140-160/90 mm/Hg) or lipids (total cholesterol > 5 mmol/l). • Impaired awareness of hypoglycaemia (Gold score 4-6 if available 4 ), or frequent hypoglycaemia (>5 episodes /week or >20% time below 4 mmol/L). • HbA1c < 6.5% (48 mmol/mol) on insulin or sulphonylureas, with other comorbidities or cognitive impairment. • eGFR 45-30 ml/min, progressive albuminuria (ACR >30). • Young patients (<40 years old) with early complications. • No diabetes review for over 18 months. These people should be seen (virtually or face-to-face) within 6 months and may need 2-3 contacts over the next 12 months. Those with none of the above risk factors are in the 'ROUTINE' category and should be informed that they may not be seen till the summer of 2021. They should be signposted to educational resources commissioned by CCGs and the new NHSE educational websites 5 and given guidance on what to do if any of their parameters change. Care providers need to allocate resource to 'rapid-support' clinics to review those whose situation changes suddenly. When using these recommendations, clinicians should take a holistic view including co-morbidities, ethnicity and socio-economic deprivation, as well as the number of factors that fall within different categories when deciding an individual's risk category. It is important to recognise that often those with associated mental health, learning, social or personality conditions may be the least likely to engage with services 6 and services should be proactive in trying to reach them. Primary care and specialist teams need to work together to identify those in 'URGENT' and 'PRIORITY' groups. Shared databases will help identify patients at risk, minimise duplication and provide joined up care between specialists and primary care teams. Where not available, specialist services may run searches from hospital admissions and laboratories to identify those with raised HbA1c and recent admissions. Primary Care, CCG or STP level approaches may include searches of primary care databases. For those with type 1 diabetes, searches of glucose data stored in the cloud can identify those with low time in range or high time below range. 7 We also need to reshape the use of our human and physical resources, moving away from a system of 3-6 month routine appointments to a system that is responsive to individual needs. We want to ensure the right person sees the right clinician at the right time in the right environment. Individual needs and preferences should determine which professional the person sees and how often, and whether appointments are physical or virtual. We are already seeing wider use of virtual consultations and learning how to do these better. We may need to merge roles so that whoever sees the person with diabetes (specialist, primary care physician doctor, nurse and dietician) collects and shares all the relevant information to minimise duplication. Some teams are piloting one stop shops to complete annual review and care processes in a single visit. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study COVID-19 and diabetes: what have we learned so far The COVID-19 pandemic: a "tech"-tonic shift toward virtual diabetes care Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia How diabetes management is adapting amid the COVID-19 pandemic Intrinsic and extrinsic factors affecting patient engagement in diabetes self-management: perspectives of a certified diabetes educator Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range